StageBio Acquires TPL Path Labs to Expand its Footprints Globally

 StageBio Acquires TPL Path Labs to Expand its Footprints Globally

StageBio Acquires TPL Path Labs to Expand its Footprints Globally

Shots:

  • StageBio and TPL Path Labs offers an expanded array of histopathology, molecular pathology, and related solutions to biopharma, medical device and academic researchers across the US, EU, and other countries
  • The acquisition expands StageBio’s pre/ clinical laboratory resources, GLP/GCLP-compliant lab facility and staff in Germany tits existing 6 GLP-compliant lab facilities and 2 GLP specimen archive sites in the US
  • The acquisition enhances StageBio ability to support clinical investigators in the areas of biomarker development, TCR and immunohistochemistry

Click here ­to­ read full press release/ article | Ref: PRNewswire | Image: Harman Professional Solutions

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post